THE FDA APPROVED THE FIRST CAR-T CELL THERAPY FOR CERTAIN PATIENTS WITH this aggressive form of LEUKEMIA The U.S. Food and Drug Administration (FDA) approved brexucabtagene autoleucel (Tecartus) for certain adult patients with B-cell...
On a web page titled “14 Diseases You Almost Forgot About (Thanks to Vaccines),” the Centers for Disease Control (CDC) remind us that the United States has eliminated or drastically reduced cases of several diseases—such as polio, measles, and...
Long-term COVID-19 effects were associated with greater mortality risk in cancer patients, and more news of the week from Cancer Today.
With targeted drugs, immunotherapies and treatment combinations now available, people with advanced melanoma have choices to make.
Treatments for small cell lung cancer have remained virtually the same for decades. Now, experts say that hope is on the horizon.
High-grade glioma, a kind of brain tumor, is difficult to treat and often fatal in children and adolescents.
Liquid biopsy tests can find tiny amounts of disease that remain after surgery and chemotherapy.
KRAS mutations were once thought to be resistant to drug therapy.
THE FDA GRANTED ACCELERATED APPROVAL TO A NEW THERAPY FOR ADVANCED CERVICAL CANCER The U.S. Food and Drug Administration (FDA) granted accelerated approval to tisotumab vedotin-tftv (Tidvak) for patients with cervical cancer that has...
An immunotherapy combination continues to be effective in treating kidney cancer patients, and more news of the week from Cancer Today.
AACR Fellow Lewis C. Cantley, PhD, leads a national effort targeting triple-negative breast cancer and ovarian cancer with a novel drug combination.
Learn More